Pharmerit (United States)
In research, Pharmerit (United States) stands highest in Medicine (#10,160 of 17,978 worldwide) and Health Sciences (#12,522 of 20,462 worldwide), over all time.
- World rank, all time
- #27,850 of 42,892
- Rank in United States
- #5,974 of 8,685
- Research works
- 260 ▲ 7% vs 2013–17
- Citations
- 3.7k 14.2 per fractional work
- Top-10% rate
- 6.5% record average 16.5%
- Open access
- 42% world 28%
What is Pharmerit (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #10,160 of 17,978 | 11.3% | 177 | |
| Health SciencesDomain | #12,522 of 20,462 | 11.2% | 187 |
Each strip is that field’s whole ranked pool, with the notch where Pharmerit (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
Who are the top researchers at Pharmerit (United States)?
Ranked on the composite score, Marc Botteman, Jennifer Stephens and Sonya J. Snedecor lead among researchers whose main affiliation is Pharmerit (United States).
- 1 Marc Botteman United States · #375,499 worldwide 105 citations · 44 works
- 2 Jennifer Stephens United States · #625,179 worldwide 43 citations · 23 works
- 3 Sonya J. Snedecor United States · #840,080 worldwide 44 citations · 15 works
- 4 Ruchit Shah United States · #977,105 worldwide 25 citations · 22 works
- 5 Shelby Corman United States · #1,002,802 worldwide 29 citations · 20 works
- 6 Viktor Chirikov United States · #1,118,642 worldwide 14 citations · 19 works
- 7 Caitlyn T. Solem United States · #1,141,712 worldwide 16 citations · 17 works
Which keywords describe research at Pharmerit (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Prognostic Factors, Immunotherapy, Cost-effectiveness Analysis, Health Utility Measures, Diagnosis and Rituximab.
- Recombinant Factor VIIa
- Inhibitors
- Population-Based Study
- Staphylococcus aureus
- Breast Cancer
- Cancer Incidence
- Healthcare-Associated Infections
- Genomic Aberrations
- Antiretroviral Therapy
- Guidelines
- Cancer Treatment
- Virulence Factors
- Global Burden
- Financial Toxicity
- Clinical Practice Guidelines
- Treatment
- Management
- Cost-effectiveness Analysis
- Prognostic Factors
- Quality of Life
- Epidemiology
- Diagnosis
- Immunotherapy
- Health Utility Measures
- Clinical Trials
- Rituximab
- Cost of Care
- Biomarkers
- Prostate Cancer
- Antimicrobial Resistance
- Clinical Management
- Therapeutic Targets
- Chronic Lymphocytic Leukemia
- PET Imaging
- Targeted Therapy
- Prophylaxis
- Lymphoma
- Genomic Profiling
- Gene Expression Profiling
- Molecular Profiling
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology42▲ 4.0×66 topics
- Quality of Life19▲ 5.5×13 topics
- Diagnosis13▲ 5.1×17 topics
- Prognostic Factors13▲ 11×9 topics
- Immunotherapy12▲ 7.3×15 topics
- Cost-effectiveness Analysis12▲ 57×1 topic
- Health Utility Measures12▲ 57×1 topic
- Management11▲ 5.3×11 topics
- Clinical Trials10▲ 6.5×13 topics
- Treatment10▲ 3.1×19 topics
- Rituximab10▲ 25×2 topics
- Clinical Practice Guidelines10▲ 6.8×10 topics
- Cost of Care8▲ 165×1 topic
- Financial Toxicity8▲ 165×1 topic
- Biomarkers8▲ 4.8×11 topics
- Global Burden8▲ 5.4×9 topics
- Prostate Cancer8▲ 19×4 topics
- Virulence Factors7▲ 15×4 topics
- Antimicrobial Resistance7▲ 10×4 topics
- Cancer Treatment7▲ 10×4 topics
- Clinical Management7▲ 12×4 topics
- Guidelines7▲ 5.3×10 topics
- Therapeutic Targets6▲ 11×2 topics
- Antiretroviral Therapy6▲ 11×6 topics
- Chronic Lymphocytic Leukemia6▲ 50×1 topic
- Genomic Aberrations6▲ 50×1 topic
- PET Imaging6▲ 11×4 topics
- Healthcare-Associated Infections6▲ 19×5 topics
- Targeted Therapy6▲ 11×4 topics
- Cancer Incidence6▲ 15×4 topics
- Prophylaxis6▲ 15×3 topics
- Breast Cancer6▲ 7.5×6 topics
- Lymphoma5▲ 14×3 topics
- Staphylococcus aureus5▲ 27×2 topics
- Genomic Profiling5▲ 20×2 topics
- Population-Based Study5▲ 33×2 topics
- Gene Expression Profiling5▲ 19×2 topics
- Inhibitors5▲ 26×2 topics
- Molecular Profiling5▲ 16×2 topics
- Recombinant Factor VIIa5▲ 45×2 topics
Which research topics does Pharmerit (United States) publish most on?
By volume in 2022–2025: Myasthenia Gravis and Thymoma, Systemic Lupus Erythematosus Research, Advanced Cellulose Research Studies and Blood groups and transfusion.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myasthenia Gravis and Thymoma Neurology 1 works
- 2 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 3 Advanced Cellulose Research Studies Biomaterials 0 works
- 4 Blood groups and transfusion Hematology 0 works
- 5 Hemoglobinopathies and Related Disorders Genetics 0 works
- 6 Iron Metabolism and Disorders Hematology 0 works
- 7 Innovative Teaching and Learning Methods Developmental and Educational Psychology 0 works
- 8 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 9 Science Education and Pedagogy Education 0 works
- 10 HIV-related health complications and treatments Emergency Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmerit (United States)'s research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bethesda
- National Institutes of Health
- National Cancer Institute
- Uniformed Services University of the Health Sciences
- National Institute of Allergy and Infectious Diseases
- Lockheed Martin (United States)
- National Heart Lung and Blood Institute
- National Institute of Mental Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.